BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19336517)

  • 21. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
    Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
    Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN and P-4E-BP1 might be associated with postoperative recurrence of rectal cancer patients undergoing concurrent radiochemotherapy.
    Zhang H; Li X; Sun W; Qin H; Li H; Yan H; Wang H; Zhang X; Zhang S; Wang H
    BMC Cancer; 2024 May; 24(1):582. PubMed ID: 38741069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
    Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
    J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer.
    Lee HW; Lee EH; Lee JH; Kim JE; Kim SH; Kim TG; Hwang SW; Kang KW
    Int J Clin Exp Pathol; 2015; 8(4):3955-62. PubMed ID: 26097581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer.
    Nawroth R; Stellwagen F; Schulz WA; Stoehr R; Hartmann A; Krause BJ; Gschwend JE; Retz M
    PLoS One; 2011; 6(11):e27509. PubMed ID: 22110663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W; Ye Q; Liu S; She QB
    Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha(1A) adrenergic receptor induces eukaryotic initiation factor 4E-binding protein 1 phosphorylation via a Ca(2+)-dependent pathway independent of phosphatidylinositol 3-kinase/Akt.
    Rybkin II; Cross ME; McReynolds EM; Lin RZ; Ballou LM
    J Biol Chem; 2000 Feb; 275(8):5460-5. PubMed ID: 10681523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E).
    Sun R; Cheng E; Velásquez C; Chang Y; Moore PS
    J Biol Chem; 2019 Aug; 294(31):11840-11852. PubMed ID: 31201269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosis.
    Chakravarthy R; Clemens MJ; Pirianov G; Perdios N; Mudan S; Cartwright JE; Elia A
    Biol Cell; 2013 Sep; 105(9):414-29. PubMed ID: 23734772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis.
    Okumura Y; Kohashi K; Tanaka Y; Kato M; Maehara Y; Ogawa Y; Oda Y
    Virchows Arch; 2020 Jun; 476(6):881-890. PubMed ID: 31927624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.
    Villalonga P; Fernández de Mattos S; Ridley AJ
    J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chronic lymphocytic leukemia.
    Shull AY; Noonepalle SK; Awan FT; Liu J; Pei L; Bollag RJ; Salman H; Ding Z; Shi H
    Oncotarget; 2015 Jun; 6(16):14632-45. PubMed ID: 25999352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilization of 4E-BP1 by PI3K kinase and its involvement in CHK2 phosphorylation in the cellular response to radiation.
    Yu ZJ; Luo HH; Shang ZF; Guan H; Xiao BB; Liu XD; Wang Y; Huang B; Zhou PK
    Int J Med Sci; 2017; 14(5):452-461. PubMed ID: 28539821
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism.
    Gingras AC; Gygi SP; Raught B; Polakiewicz RD; Abraham RT; Hoekstra MF; Aebersold R; Sonenberg N
    Genes Dev; 1999 Jun; 13(11):1422-37. PubMed ID: 10364159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif.
    Tee AR; Proud CG
    Mol Cell Biol; 2002 Mar; 22(6):1674-83. PubMed ID: 11865047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma.
    Fang Z; Lu L; Tian Z; Luo K
    Med Oncol; 2014 May; 31(5):940. PubMed ID: 24706262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
    Xu G; Zhang W; Bertram P; Zheng XF; McLeod H
    Int J Oncol; 2004 Apr; 24(4):893-900. PubMed ID: 15010827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data.
    Guo GF; Wang YX; Zhang YJ; Chen XX; Lu JB; Wang HH; Jiang C; Qiu HQ; Xia LP
    World J Gastroenterol; 2019 Apr; 25(15):1840-1853. PubMed ID: 31057298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of 4E-BP1 in the protection induced by HDLs on pancreatic beta-cells.
    Pétremand J; Bulat N; Butty AC; Poussin C; Rütti S; Au K; Ghosh S; Mooser V; Thorens B; Yang JY; Widmann C; Waeber G
    Mol Endocrinol; 2009 Oct; 23(10):1572-86. PubMed ID: 19574449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitotic CDK1 and 4E-BP1 II: A single phosphomimetic mutation in 4E-BP1 induces glucose intolerance in mice.
    Cao S; Jurczak MJ; Shuda Y; Sun R; Shuda M; Chang Y; Moore PS
    PLoS One; 2023; 18(3):e0282914. PubMed ID: 36897840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.